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Abstract
Background: The diagnosis and treatment of cancer is a major life stress such that approximately
35% of patients experience persistent clinically significant distress and carers often experience even
higher distress than patients. This paper presents the design of a two arm randomised controlled
trial with patients and carers who have elevated psychological distress comparing minimal contact
self management vs. an individualised tele-based cognitive behavioural intervention.
Methods/design: 140 patients and 140 carers per condition (560 participants in total) will been
recruited after being identified as high distress through caller screening at two community-based
cancer helplines and randomised to 1) a single 30-minute telephone support and education session
with a nurse counsellor with self management materials 2) a tele-based psychologist delivered five
session individualised cognitive behavioural intervention. Session components will include stress
reduction, problem-solving, cognitive challenging and enhancing relationship support and will be
delivered weekly. Participants will be assessed at baseline and 3, 6 and 12 months after recruitment.
Outcome measures include: anxiety and depression, cancer specific distress, unmet psychological
supportive care needs, positive adjustment, overall Quality of life.
Discussion: The study will provide recommendations about the efficacy and potential economic
value of minimal contact self management vs. tele-based psychologist delivered cognitive
behavioural intervention to facilitate better psychosocial adjustment and mental health for people
with cancer and their carers.
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Background
The mental health burden of cancer
It is estimated that from 2001 to 2011 the number of
newly diagnosed cases of cancer will increase by 29% in
women and 32% in men [1]. Cancer is the leading cause
of burden of disease and injury in Australia, accounting
for nearly one-fifth of the total disease burden [2]. The
diagnosis and subsequent treatment of cancer is a major
life stress that is followed by a range of well described psy-
chological, social, physical and spiritual difficulties [3].
While over time most people diagnosed with cancer go on
to adjust effectively to their changed life circumstances
without clinical intervention, approximately 35% will
experience persistent clinically significant distress such as
anxiety and depression, adjustment disorders, fears about
cancer recurrence, and post traumatic stress reactions, that
for some will worsen over time [4,5]. As well, many part-
ners of cancer patients report high levels of psychological
distress, sometimes even greater than that of the patients
[6,7]. The most powerful prospective predictor of longer
term distress is current distress [8,9], hence there is a clin-
ical imperative to identify patients and family members
experiencing high distress and refer those people to acces-
sible targeted psychosocial therapies [10].
A range of measures are available to screen for high psy-
chosocial distress. Memorial Sloan Kettering Cancer
Center, New York developed a simple single item Brief
Distress Thermometer (BDT) and accompanying Problem
Checklist [11] that has now been incorporated into clini-
cal practice guidelines for psychosocial care after cancer
and relevant consumer materials [12,13]. The BDT is free
of charge; and easy to administer and interpret; and has
comparable accuracy with longer distress screening instru-
ments such as the 14 item Hospital Anxiety and Distress
Scale and the 18 item Brief Symptom Inventory [14,15].
As such, the BDT is well suited for large-scale and repeated
distress screening. There is also a well-established body of
evidence demonstrating that psychosocial interventions
increase wellbeing, improve adjustment and coping and
reduce psychological distress in people affected by cancer
[10,16]. A range of effective intervention approaches have
been described using varying delivery formats, and these
include cognitive behavioural therapy, relaxation tech-
niques, psycho-education, supportive psychotherapy, and
family and couples therapy. As well, in North America and
Australia clinical practice guidelines for psychosocial care
have been developed that provide recommendations for
intervention [10,12,13,17]. However, despite the availa-
bility of guidelines and tools, evidence-based psychoso-
cial care is the exception rather than the norm. Clinicians
tend to overlook patients' psychosocial needs, often do
not recognise depression and other psychiatric illnesses in
their patients, and have limited response skills for manag-
ing patients' distress [8,18-21]. Routine screening for psy-
chological distress is uncommon in acute treatment
centres reducing the likelihood of detecting highly dis-
tressed patients and providing them with timely support
[8]. Compounding this, while some psychosocial care is
likely to be delivered to patients at diagnosis, it is uncom-
mon at the time of treatment completion and will seldom
include family members. For example, in a sample of 439
cancer patients treated at a tertiary cancer centre in
Queensland, psychosocial care information was provided
to only half of patients at diagnosis, and at the completion
of treatment to less than one third [21]. Psychosocial care
services that are responsive and accessible across the ill-
ness experience and beyond the acute treatment setting
are urgently needed.
Community-based approaches to psychosocial 
intervention
Increasingly, community based non-government organi-
sations have taken on a role as providers of support serv-
ices for cancer patients and their families. The most
prominent and easily accessed of these are tele-based
information and support services or helplines that are
now available in the UK, Netherlands, Australia and
North America [22-25]. Cancer helplines provide a poten-
tial assessment and referral point for patients and family
members for psychosocial intervention both during and
beyond their treatment experience within the acute health
care setting. In Australia the Cancer Council Cancer Hel-
pline is provided through a national toll free number
(131120) and managed by each state Cancer Council. Tel-
ephone delivery provides a broad reach that addresses
barriers to access such as geography, ill health, and cost.
The Helpline service is staffed by nurses and allied health
professionals who have experience and/or qualifications
in oncology and who undergo additional training in psy-
cho-oncology and decision support [26,27]. Helpline
operators provide brief cancer information and emotional
support typically in a single contact that includes an aver-
age of 8 minutes of verbal contact time followed by
mailed written patient education materials. The service is
underpinned by a constantly updated and extensive data
base of community and hospital based services to facili-
tate referral across sectors. The use of a centralised call cen-
tre enables standardisation of procedures to be easily
achieved with constant quality assurance, outcome moni-
toring and data collection built into the operational sys-
tem. Policies and procedures to address issues such as
confidentiality and duty of care are in place and are con-
sistent with Australian Psychological Society professional
standards and medicolegal obligations [28].
With regards to psychosocial intervention, population-
based approaches need to address not only access, but
also the costs of delivery that may impede dissemination.
For example, individualised cognitive behaviour therapy
has been found in meta-analyses to reduce anxiety and
depression after cancer with follow up periods of up toBMC Cancer 2009, 9:189 http://www.biomedcentral.com/1471-2407/9/189
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eight months [29]. While these results are impressive, this
approach will require specialist psychological staff, infra-
structure to support delivery, and compliance by patients
with routinised therapy sessions. In comparison, minimal
contact approaches to psychological care with the use of
self management materials for people with sub-threshold
depression have been found to reduce the later incidence
of major depression in patients in primary care [30]. Effi-
cacious self management has been defined as where indi-
viduals are able to monitor their own condition and
undertake the necessary cognitive, behavioural and emo-
tional responses to effect a satisfactory quality of life [31].
Self management interventions have been shown to have
consistent positive effects on mood across a range of
chronic illnesses [31] and so have great potential as a cost
effective method of providing psychological support to
people affected by cancer. Proposed advantages of self
management approaches are equity, accessibility and
choice [32]. However, it is not yet clear for which dis-
tressed patients a minimal contact approach would be
efficacious, and for whom more in depth individualised
approaches are necessary. For example, it may be that
patients and carers with borderline distress will return to
pre-morbid functioning with minimal contact approaches
while clinically distressed people will require more in
depth care to achieve similar benefits. This is a research
question that is of critical importance in order to guide the
cost-effective delivery of psychosocial oncology care serv-
ices for the population.
For practical capacity for immediate translation into the
community, psychosocial distress screening and interven-
tion should be nested within an available service infra-
structure. The Cancer Helpline provides a unique service
infrastructure with demonstrated feasibility for the deliv-
ery of well-evaluated tools to diagnose psychosocial dis-
tress and depression/anxiety in people with cancer in our
community, and their family members and carers; and
potential for the delivery of psychosocial interventions.
The Cancer Helpline has unique broad access intervention
capacity. The service has national coverage with uniform
service standards; is promoted in national patient and cli-
nician educational materials as a contact for evidence-
based cancer support and information; national media
coverage about cancer consistently uses the Cancer Hel-
pline as a referral point for the public; the use of a tele-
based delivery mode with a toll free contact number
addresses geographical, disability, illness and cost barriers
to access; the service is community based and accessible at
any point in the illness continuum. Each year nationally
over 30,000 patients and carers contact the Helpline.
However, research is needed to extend the Helpline to
include in depth psychosocial intervention; and to assess
the relative efficacy of minimal contact approaches with
individualised care. The present study will evaluate the
relative efficacy and cost-effectiveness of these two
approaches to psychosocial intervention for people dis-
tressed by cancer that are suitable for immediate popula-
tion-based translation.
Methods/design
Study aims and hypotheses
The overall aim of the proposed study is to compare the
efficacy and cost effectiveness of minimal contact self
management materials vs. a tele-based psychologist deliv-
ered cognitive behavioural intervention in improving psy-
chological outcomes for high distress cancer patients and
carers over a 12 month period. Callers who contact The
Cancer Council Cancer Helpline in Queensland and New
South Wales over a five month time period will be
screened for psychosocial distress and those callers with
elevated distress will be randomised to one of the two study
arms. The two study arms will comprise: (1) minimal con-
tact self management vs. (2) five sessions of an individu-
alised tele-based cognitive behavioural intervention
delivered by a clinical psychologist.
Study hypotheses: It is hypothesised that 3, 6, and 12
months after recruitment:
1. Participants in both study arms will experience signifi-
cant improvements in mental health compared to base-
line levels including: reduced anxiety and depression;
cancer specific distress; unmet psychological supportive
care needs; and increased positive adjustment and quality
of life.
2. Participants with borderline anxiety/depression who
receive the minimal contact self management condition
will experience significantly less anxiety and depression;
less cancer specific distress, lower unmet psychological
supportive care needs, higher positive adjustment and
improved quality of life by comparison to participants
with high anxiety/depression who receive the minimal con-
tact self management condition.
3. Participants with high anxiety/depression who receive the
individualised tele-based cognitive behavioural interven-
tion condition will experience significantly less anxiety
and depression; less cancer specific distress, lower unmet
psychological supportive care needs, higher positive
adjustment and improved quality of life by comparison
to participants with high anxiety/depression who receive the
minimal contact self management condition.
4. That from a health sector perspective, the individual-
ised tele-based cognitive behavioural intervention is more
'cost-effective' compared to the minimal contact self man-
agement comparator for high anxiety/depression partici-
pants, and minimal contact self management is more cost-
effective than the individualised tele-based cognitive
behavioural intervention for borderline anxiety/depressionBMC Cancer 2009, 9:189 http://www.biomedcentral.com/1471-2407/9/189
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participants; where $50,000 per QALY is taken as the
benchmark for cost-effectiveness in Australia.
Intervention
The 'self help' self management materials will consist of an
initial single 30-minute telephone support and education
session with a nurse counsellor who will provide feedback
to the participant about his/her levels of distress and
instruction in evidence based strategies to improve adjust-
ment. A self management manual will be developed pur-
posefully for this study that will include self help in mood/
stress management skills; problem solving approaches to
cancer-related concerns; patient education about a healthy
lifestyle to promote wellness and optimise quality of life;
strategies for mobilising personal and community support
networks to reduce isolation and seek sustainable social
support. For the individualised cognitive behavioural inter-
vention (therapist delivered), five weekly one-hour sessions
of tele-based counselling from a clinical psychologist will
be delivered that include psychoeducation, skills in stress
reduction, problem-solving, cognitive challenging and
enhancing relationship support. Cognitive behavioural
approaches are well established with regards to their clini-
cal efficacy for anxiety and depression in cancer and indi-
vidualised approaches are more effective than groups [29].
The individualised counselling sessions will follow princi-
ples of cognitive-behavioural therapy and will utilise an
adult learning approach in which participants self-select
goals to focus on during the intervention. Content will
include assigned behavioural homework that will be sup-
ported by work and tip sheets. Components that target
challenges associated with cancer treatments (e.g., pain,
sleep disturbance, fatigue) will be additionally selected if
relevant. Minutes of counselling time will be recorded for
inclusion in analyses for both arms.
Participants
Study inclusion criteria will be that the patient/carer par-
ticipants must: (1) be a cancer patient or carer ≥ 18 years
of age who has called the Cancer Helpline for information
or support (2) have a score of 4 or more on the Brief Dis-
tress Thermometer at the time of the Helpline contact (3)
be able to read and speak English (4) have no previous
history of head injury, dementia or psychiatric illness.
Callers who meet the selection criteria will be offered
entry into the study by the Helpline operator at the time
of the call; and once verbal permission to be contacted is
obtained will be posted written consent and information
forms. To minimise the period of time between calling the
Helpline and randomisation into a support arm of the
study, verbal consent to take part in the study will be
obtained by project staff and audio taped prior to written
consent. Baseline assessment will be conducted via tele-
phone interview to prevent potential delays in receiving
support. Participants will then be randomly allocated to
receive either self management or the five session cogni-
tive behavioural intervention. In all, 140 patients and 140
carers per condition will be recruited (allowing for a total
of 280 people per treatment arm; 560 participants in
total). On the basis of simulation work conducted by Rau-
denbush and Xiao-Feng [33], the present study, with 4
measurement periods and a total N of 560 will have
power of at least .90 to detect a moderate longitudinal
effect size. This sample size will allow for identification
and investigation of subgroups of patients and carers
(high vs. low/borderline distress) on the basis of their
response to psychological intervention.
Study Integrity
Ethical approval has been obtained from the Griffith Uni-
versity Human research ethics Committee. The study
design will be guided by the CONSORT statement [34].
Randomisation to study condition will occur following
the completion of baseline assessment. Assessments will
be by self-report pen and paper measures and project staff
tracking assessments will be blinded to condition. Ran-
domisation will be stratified by patient/carer and state
(QLD vs NSW) and will occur in blocks of 10, with each
condition randomly generated 5 times within each block
to ensure an unpredictable allocation sequence with equal
numbers of participants in each group at the completion
of each block. This sequence will be undertaken by the
project manager and concealed from investigators. Ther-
apy will be manualised and all intervention calls audio-
taped and reviewed to monitor treatment adherence. All
analyses will be conducted on the basis of intention to
treat.
Measures
A computer assisted telephone interview will be under-
taken for the baseline assessment; subsequent assess-
ments will be administered by mail at 3, 6 and to 12
months after recruitment. A short telephone interview at
follow-up time points will also re-assess participants' use
of support services. Primary outcomes are anxiety and
depression, cancer specific distress and unmet psycholog-
ical supportive care needs. Secondary outcomes are posi-
tive adjustment and overall quality of life.
Background variables will include socio-demographic and
disease variables (e.g. cancer site and stage, medical treat-
ments received, use of alternative therapies) and previous
(past month) and current use of support services.
Distress Screening
The single item Brief Distress Thermometer (BDT) will be
used to screen for global psychological distress [13]. This
scale has good sensitivity and specificity when used with a
cut off point of ≥ 4 [14].BMC Cancer 2009, 9:189 http://www.biomedcentral.com/1471-2407/9/189
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Psychological Distress
The Brief Symptom Inventory – 18 (BSI-18) will assess
psychological distress through three subscales of anxiety,
depression, and somatisation [35].
Cancer Specific Distress
The Impact of Events Scale (IES: [36,37]) will be used to
assess cancer specific distress. The IES has two subscales
that measure the extent to which participants are experi-
encing intrusive thoughts about cancer and avoiding
thinking about cancer [38].
Unmet Psychological Supportive Care Needs
The Supportive Care Needs Survey Short Form 34 (SCNS-
SF34) will assess cancer patients' need for help over the
last month across 5 domains: psychological, health sys-
tems and information, patient care and support, physical
and daily living, and sexuality needs [39,40]. The Support-
ive Care Needs Survey for Partners and Caregivers (SCNS-
P&C45) will assess carers' need for help over the last
month.
Positive Adjustment
Positive adjustment will be measured with a 21-item Post-
traumatic Growth Inventory (PTGI) assessing perceived
positive life changes occurring after a diagnosis of cancer
[41]. Domains assessed include strengthened relation-
ships with others, appreciation of life, personal strength,
new priorities, spiritual/religious growth.
Quality of Life
Health related quality of life will be measured with the
Assessment of Quality of Life – 2 (AQoL-2), which is a
more recent version of the original 15-item AQol. The
AQoL-2 is a 20-item scale assessing quality of life on six
dimensions; including independent living, social, mental
health, coping, pain, and sensory perception [42]. The
AQoL will also be used to assess the cost-effectiveness of
the intervention options. AQoL utility data analysis will
be used to estimate Quality-adjusted life years (QALYs).
Statistical Analyses
The study is a multivariate, two condition randomized
controlled trial with repeated measures across time. The
analytic approach will be a multilevel model (MLM) in
which measurement occasions (level 1) are nested within
persons (level 2) and in which state/program differences
are represented as a fixed effect at level 2 whose interac-
tion with time represents differential adjustment and dis-
tress trajectories for the two groups. A key advantage of
this approach is flexibility in dealing with missing data
owing either to random or non-random attrition. Further,
subgroups of patients and carers who respond differen-
tially to the program will be identified using growth mix-
ture modelling that is a related longitudinal procedure
that identifies cases with similar distress and adjustment
trajectories across time [43]. Jo's [44] results suggest that
the proposed sample size will be sufficient to examine
subgroups of responders.
Economic Analyses
A trial-based economic evaluation will be conducted that
integrates the efficacy and quality of life outcomes data
with comparative cost data on the intervention options.
The various distress indicators and the unmet needs data
will be built in incremental cost-effectiveness analysis
(CEA), while the quality of life data will be used in cost-
utility analysis (CUA) using the Brazier algorithm. The
feasibility of adding a modelled economic evaluation (to
broaden the target population; lengthen the time horizon
beyond that of the trial; and estimate cost offsets) will also
be carefully assessed, having regard to trial results and the
strength of evidence in the literature to underpin key
modelling assumptions.
Costs and outcomes will be assessed from a health sector
perspective, but with a focus on 'government as 3rd party
funder'. Cost impacts that fall on patients and their carers/
families will be reported to the extent they can be assessed
from the activity data; but this collection will not be com-
plete. Pathway analysis and patient flowcharts (incorpo-
rating decision tree analysis) will be used to clearly
identify and cost the activity components for each arm of
the trial. Standard discounting will be applied to both
costs and outcomes, together with detailed sensitivity test-
ing (using @RISK probabilistic software).
Discussion
This study will address a critical research question: what is
the efficacy and cost-effectiveness of population based
strategies for promoting optimal psychosocial adjustment
and mental health for people with cancer and their carers
who are at risk? To date, intervention studies have typi-
cally not been adequately powered to look differentially at
effects for high versus borderline/low distress patients and
carers; or included economic analyses for cost-benefit.
This research will overcome these limitations. Most
importantly however, the proposed study will also pro-
vide a strategy for delivering in depth intervention to high
distress individuals that can be immediately translatable
into broad reach tele-health services both in Australia and
internationally; and potentially replicated for other
chronic illnesses.
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